Structure Therapeutics Inc.
Price Action
Technical Summary
CONSOLIDATINGStructure Therapeutics Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 80), indicating clear outperformance against the broad market. Earnings contraction of 30% provides fundamental context to the price action. However, with RSI at 77, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $47.10 | +20.25% | ABOVE |
| 50 SMA | $42.65 | +32.77% | ABOVE |
| 100 SMA | $49.62 | +14.12% | ABOVE |
| 150 SMA | $56.45 | +0.32% | ABOVE |
| 200 SMA | $49.86 | +13.58% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is GPCR in an uptrend right now?
GPCR has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is GPCR overbought or oversold?
GPCR's RSI (14) is 77. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is GPCR outperforming the market?
GPCR has a Relative Strength (RS) Rating of 80 out of 99. Yes, GPCR is a market leader, outperforming 80% of all stocks over the past 12 months.
Where is GPCR in its 52-week range?
GPCR is trading at $56.63, which is 60% of its 52-week high ($94.90) and 52% above its 52-week low ($15.80).
How volatile is GPCR?
GPCR has a Beta of 1.09 and 52-week volatility of 62%. It's more volatile than the S&P 500 - expect bigger swings.